Finnish biotech company Volare today announces the closing of a €26 million funding round to build Volare 01 – a facility set to become the most efficient protein production plant in the world, and to advance its unique technology. Located in Pori, Finland, the facility will serve as a cornerstone in scaling Volare’s proprietary insect protein technology.